Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
28 Enero 2025 - 7:07PM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Amendment No. 28 to Schedule 13D, dated January 28, 2025, relating to the Common Shares, no par value, of Lineage Cell Therapeutics,
Inc. shall be filed on behalf of the undersigned.
Dated: January 28, 2025 |
Broadwood Partners, L.P.
|
|
By: |
Broadwood Capital, Inc. |
|
|
|
By: |
/s/ Neal C. Bradsher |
|
Name: |
Neal C. Bradsher |
|
Title: |
President |
|
|
|
|
|
|
|
Broadwood Capital, Inc. |
|
|
|
By: |
/s/ Neal C. Bradsher |
|
Name: |
Neal C. Bradsher |
|
Title: |
President |
|
|
|
|
|
|
|
/s/ Neal C. Bradsher |
|
Neal C. Bradsher |
Lineage Cell Therapeutics (AMEX:LCTX)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Lineage Cell Therapeutics (AMEX:LCTX)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025